Drug intelligence / Profile preview

OsteoActivator-C (Osteo-Pharma)

Development stage: Preclinical
Lead developer: Osteo Pharma
Modality: Small Molecules
Administration: Implant

Overview

OsteoActivator-C is a drug-device combination product developed by Osteo Pharma. It consists of orthopedic implants (such as screws) coated with a proprietary biodegradable PLGA-based coating that provides local, sustained release of testosterone and alendronate. This combination therapy is designed to enhance the osseointegration of orthopedic implants and treat bone defects. Testosterone acts locally to promote osteoblast-mediated bone formation, while alendronate inhibits osteoclast-mediated bone resorption. Together, they work synergistically to increase bone-implant contact and adjacent bone formation, preventing implant loosening. The product is currently in preclinical development.

Brand names: OsteoActivator-C
Other names: OsteoActivator C

Targets

FDPS (Farnesyl pyrophosphate synthase)AR (Adrenergic receptors)

Beyond the preview

Go deeper on OsteoActivator-C (Osteo-Pharma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OsteoActivator-C (Osteo-Pharma).

Explore the full profile